Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 5,000 shares at $13.36 ($67K) on 2022-12-01, disclosed to the SEC on 2022-12-02.
Open-market sale of $67k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |
| AKYA | SELL | 2022-11-14 | $375K | — | Filing → |